Vietnam’s pharmaceutical market is expected to have a year of optimism after experiencing a multicoloured gamut in 2024.

"Trump might forget about Greenland. But also, he might not. Nobody knows. He operates on whims," @anneapplebaum writes.

These diabetes and weight loss drugs work by slowing digestion and curbing ... In a statement sent to USA TODAY, a spokesperson for drug maker Novo Nordisk said the company welcomes any ...

and to work with like-minded suppliers. One way to ensure that Novo Nordisk’s approach to sustainability is carried through all parts of the business has been the way it has approached educating ...

More: Medicare targets popular weight loss drugs Ozempic, Wegovy for price negotiations These diabetes and weight loss drugs work by slowing digestion and ... a spokesperson for drug maker Novo ...

All authors approved the final version of the manuscript, including the authorship list, and agreed to be accountable for all aspects of the work in ensuring that questions ... Inc., NGM ...

And regarding the slower-than-expected sales in the industry, Novo Nordisk's work goes beyond diabetes and obesity, which are currently its core areas. The drugmaker has been looking to diversify ...

LONDON/COPENHAGEN, Feb 5 (Reuters) - Novo Nordisk emissions grew 23% in 2024, the company said on Wednesday, and will keep rising through the end of the decade as it boosts production of ...

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn ...

Novo Nordisk reported strong data for its next-gen anti-obesity medicine. The Danish company has an excellent weight loss drug pipeline. But it's also diversifying its lineup and offering other perks.